Tuberculosis Infection, Latent
9
2
2
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (9)
Screening With Portable X-rays for Rapid Recognition of TB
SCAF-TB - Saving Children and Their Families From Tuberculosis: Implementation Research to Improve TB Preventive Treatment Initiation and Completion Rates Among Contact Persons in Tajikistan and Tanzania
Shaping a Community-based Pathway to Improve TB Surveillance Among African and Hindustan Immigrants Experiencing Vulnerabilities
Rifapentine-Based Shorter Regimens for Tuberculosis and TB Infection in Kazakhstan
Shorter and Safer Treatment Regimens for Latent TB
Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
Burden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-Bissau
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial